ECSP013979A - Formulación de tabletas de oxazolidinona - Google Patents

Formulación de tabletas de oxazolidinona

Info

Publication number
ECSP013979A
ECSP013979A EC2001003979A ECSP013979A ECSP013979A EC SP013979 A ECSP013979 A EC SP013979A EC 2001003979 A EC2001003979 A EC 2001003979A EC SP013979 A ECSP013979 A EC SP013979A EC SP013979 A ECSP013979 A EC SP013979A
Authority
EC
Ecuador
Prior art keywords
oxazolidinone
tablets
formulation
provides
antibacterial agent
Prior art date
Application number
EC2001003979A
Other languages
English (en)
Inventor
Homer Lin
Ken Yamamoto
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22703542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP013979(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ECSP013979A publication Critical patent/ECSP013979A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La presente invención proporciona una tableta comprimida de un agente antibacteriano de oxazolidinona que provee una alta carga de fármaco y una excelente biodisponibilidad.
EC2001003979A 2000-03-22 2001-03-22 Formulación de tabletas de oxazolidinona ECSP013979A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19096900P 2000-03-22 2000-03-22

Publications (1)

Publication Number Publication Date
ECSP013979A true ECSP013979A (es) 2002-01-25

Family

ID=22703542

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2001003979A ECSP013979A (es) 2000-03-22 2001-03-22 Formulación de tabletas de oxazolidinona

Country Status (33)

Country Link
EP (1) EP1265608B1 (es)
JP (1) JP2003527424A (es)
KR (2) KR20070094673A (es)
CN (1) CN1208058C (es)
AR (1) AR033357A1 (es)
AT (1) ATE412413T1 (es)
AU (2) AU2001243243B2 (es)
BG (1) BG107117A (es)
BR (1) BR0108846A (es)
CA (1) CA2400118A1 (es)
CZ (1) CZ20023133A3 (es)
DE (1) DE60136341D1 (es)
DK (1) DK1265608T3 (es)
EA (1) EA006772B1 (es)
EC (1) ECSP013979A (es)
ES (1) ES2312422T3 (es)
HK (1) HK1054325B (es)
HR (1) HRP20020765A2 (es)
HU (1) HUP0300378A3 (es)
IL (1) IL151788A0 (es)
MX (1) MXPA02009316A (es)
MY (1) MY136370A (es)
NO (1) NO20024505D0 (es)
NZ (1) NZ521525A (es)
PE (2) PE20011126A1 (es)
PL (1) PL201686B1 (es)
PT (1) PT1265608E (es)
SK (1) SK12092002A3 (es)
TW (1) TWI293028B (es)
UA (1) UA77654C2 (es)
WO (1) WO2001070225A2 (es)
YU (1) YU69802A (es)
ZA (1) ZA200207073B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
DK1749517T3 (da) * 2005-07-20 2008-11-03 Teva Pharma Stabil farmaceutiske sammensætning af linezolid form IV
WO2010026597A1 (en) * 2008-09-02 2010-03-11 Hetero Research Foundation Oral dosage forms of linezolid and processes for their preparation
EA027791B1 (ru) * 2010-11-24 2017-09-29 Мелинта Терапьютикс, Инк. Фармацевтические композиции
WO2013088389A1 (en) * 2011-12-14 2013-06-20 Alembic Pharmaceuticals Limited Linezolid premix
CN103505459B (zh) * 2012-06-20 2016-02-24 北京万生药业有限责任公司 利奈唑胺药物组合物
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
NZ735973A (en) 2015-04-01 2023-06-30 Akebia Therapeutics Inc Compositions and methods for treating anemia
CN106727396A (zh) * 2016-11-22 2017-05-31 湖北广济药业股份有限公司 一种ⅱ晶型利奈唑胺片及其制备方法
CN109481412A (zh) * 2018-08-17 2019-03-19 扬子江药业集团北京海燕药业有限公司 一种ii晶型利奈唑胺片及其制备工艺
WO2021216530A1 (en) 2020-04-20 2021-10-28 Akebia Therapeutics, Inc. Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) * 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
EP1181288B1 (en) * 1999-05-27 2003-07-30 PHARMACIA & UPJOHN COMPANY Bicyclic oxazolidinones as antibacterial agent

Also Published As

Publication number Publication date
AU4324301A (en) 2001-10-03
DK1265608T3 (da) 2008-12-08
NO20024505L (no) 2002-09-20
MY136370A (en) 2008-09-30
PE20020499Z (es) 2002-07-12
PL201686B1 (pl) 2009-04-30
KR100786410B1 (ko) 2007-12-17
BR0108846A (pt) 2003-05-06
SK12092002A3 (sk) 2002-12-03
HUP0300378A3 (en) 2004-11-29
HK1054325B (zh) 2006-01-13
EP1265608A2 (en) 2002-12-18
UA77654C2 (en) 2007-01-15
DE60136341D1 (de) 2008-12-11
PT1265608E (pt) 2008-12-15
CN1418097A (zh) 2003-05-14
ES2312422T3 (es) 2009-03-01
HUP0300378A2 (hu) 2003-06-28
BG107117A (bg) 2003-05-30
WO2001070225A2 (en) 2001-09-27
YU69802A (sh) 2005-11-28
TWI293028B (en) 2008-02-01
HRP20020765A2 (en) 2003-12-31
ZA200207073B (en) 2003-12-03
CZ20023133A3 (cs) 2003-01-15
EA006772B1 (ru) 2006-04-28
WO2001070225A3 (en) 2001-12-13
CN1208058C (zh) 2005-06-29
ATE412413T1 (de) 2008-11-15
AU2001243243B2 (en) 2004-10-14
NO20024505D0 (no) 2002-09-20
AR033357A1 (es) 2003-12-17
MXPA02009316A (es) 2004-04-05
PE20011126A1 (es) 2001-10-31
KR20070094673A (ko) 2007-09-20
NZ521525A (en) 2004-02-27
EA200201006A1 (ru) 2003-02-27
HK1054325A1 (zh) 2003-11-28
EP1265608B1 (en) 2008-10-29
KR20020083185A (ko) 2002-11-01
IL151788A0 (en) 2003-04-10
CA2400118A1 (en) 2001-09-27
PL366067A1 (en) 2005-01-24
JP2003527424A (ja) 2003-09-16

Similar Documents

Publication Publication Date Title
ES2545205T3 (es) Combinación de azelastina y ciclesonida
DOP2006000050A (es) Una formulación sólida de dosificación farmaceútica
DE60326709D1 (de) Pharmazeutische formulierungen mit verbesserter bioverfügbarkeit
UY28281A1 (es) Productos farmacéuticos
PE20000559A1 (es) Formulacion de tabletas comprimidas de efavirenz
ATE476957T1 (de) Pharmazeutische zusammensetzung auf fondantbasis
BR9814743A (pt) Tablete de detergente
ITTO20010005A1 (it) Formulazione farmaceutica.
ATE331537T1 (de) Topisch anwendbare arzneimittelformulierung
AR034517A1 (es) Formulacion farmaceutica
AR033467A1 (es) Comprimido de meloxicam de rapida disgregacion
BR0108846A (pt) Formulação de oxazolidinona em comprimido
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
HUP0303860A3 (en) A pharmaceutical tablet having a high active ingredient
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
DE60022689D1 (de) Pharmazeutische desinfektionsmittel, die usninsäure und ein ätherisches öl enthalten
ATE296606T1 (de) Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon
UY27170A1 (es) Formulación de medicamento que contiene un agente agonista muscarínico
ATE331509T1 (de) Zusammensetzung die paracetamol und niflumic säure enthält
ECSP982436A (es) Composicion
PT102453B (pt) Formulacao de um composto cefalosporinico e estojo compreendendo o referido composto e uma solucao aquosa tamponada
UY27345A1 (es) Formulación farmacéutica.
MY158344A (en) Oral drug delivery system
AR004624A1 (es) Tableta de carbonil-hierro de compresion directa.
TW200631607A (en) Oral drug delivery system